We are live on
!
Find out more
PA
PharVision Advisers Portfolio holdings
AUM
$9.86M
1-Year Est. Return
9.93%
This Fund
S&P 500
This Quarter
Est. Return
-7.09%
1 Year Est. Return
+9.93%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$9.86M
AUM Growth
-$188M
(-95%)
Cap. Flow
-$186M
Cap. Flow
% of AUM
-1,882.29%
Top 10 Holdings %
Top 10 Hldgs %
17.98%
Holding
708
New
41
Increased
5
Reduced
51
Closed
611
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ACV Auctions
ACVA
|
+$194K |
| 2 |
Rapid7
RPD
|
+$183K |
| 3 |
EFC
Ellington Financial
EFC
|
+$181K |
| 4 |
Banco Santander
SAN
|
+$159K |
| 5 |
Oscar Health
OSCR
|
+$155K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EXL Service
EXLS
|
+$830K |
| 2 |
Delek US
DK
|
+$724K |
| 3 |
Broadcom
AVGO
|
+$669K |
| 4 |
Itron
ITRI
|
+$666K |
| 5 |
Brinker International
EAT
|
+$649K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 17.83% |
| 2 | Technology | 15.87% |
| 3 | Healthcare | 10.98% |
| 4 | Industrials | 10.86% |
| 5 | Real Estate | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
General Motors
GM
$71.7B
| – | – |
-2,471
| Closed | -$201K |
|
327
Genie Energy
GNE
$373M
| – | – |
-13,628
| Closed | -$188K |
|
328
Gentex
GNTX
$5.1B
| – | – |
-15,353
| Closed | -$357K |
|
|
B
329
Barrick Mining
B
$60.9B
| – | – |
-5,627
| Closed | -$245K |
|
|
GOOD
330
Gladstone Commercial Corp
GOOD
$631M
| – | – |
-13,157
| Closed | -$140K |
|
331
Genuine Parts
GPC
$16.8B
| – | – |
-2,822
| Closed | -$347K |
|
332
Green Plains
GPRE
$1.18B
| – | – |
-29,530
| Closed | -$289K |
|
333
Grab
GRAB
$14.3B
| – | – |
-41,287
| Closed | -$206K |
|
|
GRRR
334
Gorilla Technology Group
GRRR
$337M
| – | – |
-19,966
| Closed | -$218K |
|
335
GitLab
GTLB
$5.55B
| – | – |
-5,535
| Closed | -$208K |
|
336
Guidewire Software
GWRE
$11.9B
| – | – |
-1,040
| Closed | -$209K |
|
337
GXO Logistics
GXO
$6.22B
| – | – |
-4,579
| Closed | -$241K |
|
338
Hanmi Financial
HAFC
$958M
| – | – |
-10,764
| Closed | -$291K |
|
339
Haemonetics
HAE
$3.55B
| – | – |
-3,537
| Closed | -$283K |
|
340
Hayward Holdings
HAYW
$3.05B
| – | – |
-18,458
| Closed | -$285K |
|
341
HCA Healthcare
HCA
$82.2B
| – | – |
-465
| Closed | -$217K |
|
342
Hagerty
HGTY
$1.21B
| – | – |
-14,937
| Closed | -$201K |
|
|
HI
343
DELISTED
Hillenbrand
HI
| – | – |
-9,859
| Closed | -$313K |
|
344
Hamilton Lane
HLNE
$3.7B
| – | – |
-2,074
| Closed | -$279K |
|
345
Helix Energy Solutions
HLX
$1.39B
| – | – |
-45,423
| Closed | -$285K |
|
|
HOLX
346
DELISTED
Hologic
HOLX
| – | – |
-6,803
| Closed | -$507K |
|
347
Honeywell
HON
$71.7B
| – | – |
-1,177
| Closed | -$230K |
|
348
Robinhood
HOOD
$95.5B
| – | – |
-1,957
| Closed | -$221K |
|
349
Helmerich & Payne
HP
$3.37B
| – | – |
-9,886
| Closed | -$284K |
|
|
HPP
350
Hudson Pacific Properties
HPP
$800M
| – | – |
-21,987
| Closed | -$238K |
|
Similar funds
WA
BS
RG
MP
AIA
CCM
DFA
T
PharVision Advisers's Q1 2026 Portfolio in Review
As of Q1 2026, PharVision Advisers held 708 positions worth $9.86M, down 95% from $198M the previous quarter. Its ten largest holdings account for 18% of the portfolio.
PharVision Advisers withdrew a net $186M in Q1 2026, closing 611 positions and reducing 51 holdings. Its most notable exit was EXL Service, an estimated $830K position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
Against the trend, PharVision Advisers opened a new position in ACV Auctions worth $125K.
- PharVision Advisers's largest Q1 2026 buy was ACV Auctions: 29,579 shares worth $125K.
- PharVision Advisers added most to Embecta in Q1 2026, an estimated $48.4K increase.
- PharVision Advisers's biggest Q1 2026 reduction was Herbalife, cutting an estimated $621K.
- PharVision Advisers fully exited EXL Service in Q1 2026, selling an estimated $830K.
- PharVision Advisers's ten largest holdings make up 18% of its $9.86M portfolio in Q1 2026.
- PharVision Advisers opened 41 new positions and closed 611 in Q1 2026.
- PharVision Advisers's portfolio value fell 95% quarter-over-quarter to $9.86M.
Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.